Building an agile organization (Material Aspect 2)
At the core of UCB’s mission is the improvement of the life of persons living with severe chronic diseases, including enhanced access to existing treatments, a tailored design and clinical development of new molecules and solutions for patients.
Adapting a holistic view of patients and their access to quality care resulted in a new business model with an alignment of UCB’s talents, tailored to enhance accountability, responsibility, preparation of and engagement for the future, as well as to advance sustainable growth and opportunities. Employees are focused on creating value from medical and scientific innovation for persons living with sever chronic diseases. Understanding and shaping knowledge about disease mechanisms at their genetic, cellular and physiopathological level is critical to advancing breakthrough treatment choices. This interconnecting innovation is critical for accelerating the sustainability of quality care.
In 2016, UCB strengthened the organization to become the patient preferred biotech leader. The shared purpose ‘create value for patients’ is the foundation of our inspiration and influences our behaviors: acting responsibly, being accountable, being engaged and demonstrating agility.
With this ambition at the core, decisions are looked at afresh by each function considering an overarching principle that the patient is at the heart of UCB processes and planning. As a consequence, UCB organized the workforce into four ‘Patient Value Organization’ pillars.
UCB adopted this approach to enable a proper resource allocation, to foster cultural diversity, and to integrate and exhibit strong and inclusive leadership, in order to support the execution of the company’s vision.